[309 Pages Report] The breast lesion localization market is expected to strengthen its hold on the global market at an average CAGR of 4.1% between 2022 and 2032. The market is valued at US$ 256 Mn in 2022 and is likely to reach US$ 382 Mn by 2032. Previously, the market was thriving at a slightly higher CAGR of 4.9% (2015-2021), ensuring a market size of US$ 244 Million in 2021.
“Rising cases of breast cancer led by increased government spending on the research and development of drugs and services to counter the disease are flourishing the breast lesbian localization market, enhancing the healthcare structure while spreading awareness about the early diagnosis.”
Monitoring and diagnosis of cancer gain a lot of market traction for the breast lesion localization market. The increased use of advanced healthcare tools and services is leading breast cancer detection easy and confined. With the help of breast lesion localization services, the processes of imaging, screening, and scanning become smooth and easy.
As the market grows in the regions where breast cancer is the most common cancer among a lot of regions, it is attributed to the growth of the breast lesion localization market.
| Attributes | Details |
|---|---|
| Breast Lesion Localization Market CAGR (2022-2032) | 4.1% |
| Breast Lesion Localization Market Value (2022) | US$ 256 Million |
| Breast Lesion localization Market Value (2032) | US$ 382 Million |
A global study on the Breast lesion localization market shows that the rising breast cancer cases in the region are the driving factor for the market, coupled with the growing awareness around the new technologies coming into the diagnostics and healthcare sector is increasing the sales of breast lesion localization services.
Breast cancer’s early detection and screening, and treatment, according to that diagnosis, have gained a good amount of traction in the breast lesion localization market. Breast cancer is the second leading cancer-related death in women worldwide. Integration of the latest diagnosis practices with cutting-edge healthcare also makes the screening process easy.
The chances of getting breast cancer increase with the growing age as a type of adult stem cell at the root cause of breast cancer. This directly affects the myoepithelial cells, which eventually line the breast’s milk-producing liminal cells and works as tumor suppressors.
American cancer society explains that one out of eight women gets breast cancer under 45 of age. Though the number differs for women who are older than 45 years of age, approximately 2 out of 3 women develop invasive breast cancer.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Breast lesion localization market analysis has focused on explaining how the advent of covid-19 has shaped various markets differently. It has adversely affected some markets, damaging the supply chains, nullifying the distribution channels, and pushing markets towards turmoil. However, it has also been beneficial for a set of markets, especially the healthcare and diagnostics market.
People have become more aware of their health and keep a check on their vitals and health conditions through multiple diagnosis processes. Breast cancer, being one of the most common cancers out there, needs breast lesion localization services. People diagnosed with breast cancer have higher chances of getting covid-19 as their immunity is already low.
Breast lesion localization involves early detection and screening of breast cancer so it can be cured as soon as possible. The lockdown and travel restrictions affected the market’s growth in the first quarter of the pandemic, but as soon as diagnostic services started functioning, the market came back on track with a healthy growth rate.
Other components of the market also grow parallel, like breast biopsy, shaping the trends of the breast lesion localization market. These fuels the sales of breast lesion localization services in new regions.
“Rising chronic diseases like breast cancer and multiple diagnosis methods including early detection and screening coupled with it being the most prevalent cancer are helping the breast lesion localization market gain traction”
The government initiatives are working in order to spread awareness around breast cancer, diagnosis, symptoms, surgeries, and stages that help people in fighting against breast cancer.
Government programs also promote multiple kinds of diagnosis, treatment, and screening processes that help doctors and patients understand the real-time situation, pushing the demand for breast lesion localization. Another factor that creates multiple opportunities for the market is the high capital investments of emerging economies like India and China in their healthcare sector.
These countries are currently upgrading or building their healthcare structure, spending huge amounts on the development of the infrastructure. Countries also run programs to welcome the companies that provide a direct supply chain to healthcare and diagnostics services.
The shortage of oncologists is limiting the sales of breast lesion localization systems that perform by skilled professionals. The localization of tumors, lymphedema, seroma and risk of healthy tissue excision are some of the processes that breast lesion localization has.
Other reasons that restrict the market’s growth are the FDA approvals and the uncertainty attached to it. Players that operate the breast lesion localization need to obtain nuclear regulatory clearance to get listed among the registered operators.
Principal Consultant
The breast lesion localization market is categorized by type and usage. These categories are further divided into small segments that expand their channels in multiple market spaces. These segments perform differently in multiple markets as they have a stronghold in multiple regions.
The type category is segmented into wire localization, radioisotope localization, magnetic localization, and electromagnetic localization, while the usage category is divided into breast biopsy and breast conservation (Lumpectomy).
By usage, the breast biopsy segment is the largest segment and will hold the biggest portion of the market in the forecast period. The analysis shows that the breast biopsy segment is set to thrive at a CAGR of 3.5% in the forecast period, while previously, the segment was thriving at a slightly higher CAGR of 4.0%.
Breast lesion localization market analysis explains that the factors behind the growth of this segment are its easy removal and short time span, and lower post-surgery impacts than the lumpectomy. Also, the breast biopsy can be used to remove an abnormality within the breast, while lumpectomy (Partial mastectomy) can only be used to remove breast cancer. These factors flourish the demand for breast lesion localization market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The breast lesion localization market is divided into regions; North America, Latin America, Asia Pacific, Middle East and Africa (MEA), and Europe. The biggest market is the United States, which is flourishing at a CAGR of 3.9% between 2022-2032.
The region is likely to hold a market revenue of US$ 136.3 Mn by the end of 2032. Increasing breast cancer cases coupled with advanced diagnosis options while upgrading the healthcare system and their integration with the latest technology like AI and IOT are fueling the growth in this region.
The UK is the highest growing market globally and will hold US$ 18.2 Mn by the end of 2032 as it thrives on a promising CAGR of 4.4% between 2022-2032. Other regions like Asia pacific also flourished, with developing countries like China booming at a CAGR of 3.6% and Japan growing at a CAGR of 3.8%, while their projected values are US$ 28 Mn and US$ 25.2 Mn, respectively.
| Regions | CAGR (2022-2032) |
|---|---|
| United States | 3.9% |
| United Kingdom | 4,4% |
| China | 3.6% |
| Japan | 3.8% |
| South Korea | 3.0% |
The competitive landscape of breast lesion localization is dynamic in nature and allows new competitors to thrive in the market and increase competitiveness. The companies in the market are a part of mergers and collaborations that result in increased distribution channels and market spaces. These companies focus on updating the price ranges, while making the platforms more patient friendly.
Recent Developments in the Breast Lesion Localization Market:
The breast lesion localization market is set to grow at a CAGR of 4.1% through 2032.
North America is the biggest region in breast lesion localization market that is flourishing at at a CAGR of 3.5 by 2032.
Breast Biopsy is the leading segment in the breast lesion localization market by usage, thriving at a CAGR of 3.5% through 2032.
United Kingdom has the highest growth potential in the breast lesion localization market, thriving at CAGRs of 3.5% through 2032.
1. Executive Summary
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Breast Lesion Localization Demand
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Mn)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
4. Market Background and Foundation Data Points
4.1. Global Protective Coatings Market (US$ Mn)
4.2. Breast Lesion Localization Market Opportunity Assessment (US$ Mn)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors - Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Global Protective Coatings Market Growth
4.5.3. Breast Lesion Localization Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Breast Lesion Localization Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking
6. Global Breast Lesion Localization Market Demand Analysis 2015-2021 and Forecast, 2022-2032
6.1. Historical Market Analysis, 2015-2021
6.2. Current and Future Market Projections, 2022-2032
6.3. Y-o-Y Growth Trend Analysis
7. Global Breast Lesion Localization Market Value Analysis 2015-2021 and Forecast, 2022-2032
7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Breast Lesion Localization Market Analysis 2015-2021 and Forecast 2022-2032, By Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Type, 2015-2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Type, 2022-2032
8.3.1. Wire Localization
8.3.2. Radioisotope Localization
8.3.3. Magnetic Localization
8.3.4. Electromagnetic Localization
8.3.5. Other Localization Methods
8.4. Market Attractiveness Analysis By Type
9. Global Breast Lesion Localization Market Analysis 2015-2021 and Forecast 2022-2032, By Usage
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Usage, 2015-2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Usage, 2022-2032
9.3.1. Breast Biopsy
9.3.2. Breast Conservation (Lumpectomy)
9.4. Market Attractiveness Analysis By Usage
10. Global Breast Lesion Localization Market Analysis 2015-2021 and Forecast 2022-2032, By Region
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021
10.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. Asia Pacific
10.3.5. Middle East and Africa (MEA)
10.4. Market Attractiveness Analysis By Region
11. North America Breast Lesion Localization Market Analysis 2015-2021 and Forecast 2022-2032
11.1. Introduction
11.2. Pricing Analysis
11.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
11.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
11.4.1. By Country
11.4.1.1. U.S.
11.4.1.2. Canada
11.4.1.3. Rest of North America
11.4.2. By Type
11.4.3. By Usage
11.5. Market Attractiveness Analysis
11.5.1. By Country
11.5.2. By Type
11.5.3. By Usage
12. Latin America Breast Lesion Localization Market Analysis 2015-2021 and Forecast 2022-2032
12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
12.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
12.4.1. By Country
12.4.1.1. Brazil
12.4.1.2. Mexico
12.4.1.3. Rest of Latin America
12.4.2. By Type
12.4.3. By Usage
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Type
12.5.3. By Usage
13. Europe Breast Lesion Localization Market Analysis 2015-2021 and Forecast 2022-2032
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
13.4.1. By Country
13.4.1.1. Germany
13.4.1.2. France
13.4.1.3. U.K.
13.4.1.4. Italy
13.4.1.5. Benelux
13.4.1.6. Nordic Countries
13.4.1.7. Rest of Europe
13.4.2. By Type
13.4.3. By Usage
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Type
13.5.3. By Usage
14. Asia Pacific Breast Lesion Localization Market Analysis 2015-2021 and Forecast 2022-2032
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
14.4.1. By Country
14.4.1.1. China
14.4.1.2. Japan
14.4.1.3. South Korea
14.4.1.4. Rest of Asia Pacific
14.4.2. By Type
14.4.3. By Usage
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Type
14.5.3. By Usage
15. Middle East and Africa Breast Lesion Localization Market Analysis 2015-2021 and Forecast 2022-2032
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
15.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
15.4.1. By Country
15.4.1.1. GCC Countries
15.4.1.2. South Africa
15.4.1.3. Turkey
15.4.1.4. Rest of Middle East and Africa
15.4.2. By Type
15.4.3. By Usage
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Type
15.5.3. By Usage
16. Key Countries Breast Lesion Localization Market Analysis 2015-2021 and Forecast 2022-2032
16.1. Introduction
16.1.1. Market Value Proportion Analysis, By Key Countries
16.1.2. Global Vs. Country Growth Comparison
16.2. US Breast Lesion Localization Market Analysis
16.2.1. Value Proportion Analysis by Market Taxonomy
16.2.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
16.2.2.1. By Type
16.2.2.2. By Usage
16.3. Canada Breast Lesion Localization Market Analysis
16.3.1. Value Proportion Analysis by Market Taxonomy
16.3.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
16.3.2.1. By Type
16.3.2.2. By Usage
16.4. Mexico Breast Lesion Localization Market Analysis
16.4.1. Value Proportion Analysis by Market Taxonomy
16.4.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
16.4.2.1. By Type
16.4.2.2. By Usage
16.5. Brazil Breast Lesion Localization Market Analysis
16.5.1. Value Proportion Analysis by Market Taxonomy
16.5.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
16.5.2.1. By Type
16.5.2.2. By Usage
16.6. Germany Breast Lesion Localization Market Analysis
16.6.1. Value Proportion Analysis by Market Taxonomy
16.6.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
16.6.2.1. By Type
16.6.2.2. By Usage
16.7. France Breast Lesion Localization Market Analysis
16.7.1. Value Proportion Analysis by Market Taxonomy
16.7.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
16.7.2.1. By Type
16.7.2.2. By Usage
16.8. Italy Breast Lesion Localization Market Analysis
16.8.1. Value Proportion Analysis by Market Taxonomy
16.8.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
16.8.2.1. By Type
16.8.2.2. By Usage
16.9. BENELUX Breast Lesion Localization Market Analysis
16.9.1. Value Proportion Analysis by Market Taxonomy
16.9.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
16.9.2.1. By Type
16.9.2.2. By Usage
16.10. UK Breast Lesion Localization Market Analysis
16.10.1. Value Proportion Analysis by Market Taxonomy
16.10.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
16.10.2.1. By Type
16.10.2.2. By Usage
16.11. Nordic Countries Breast Lesion Localization Market Analysis
16.11.1. Value Proportion Analysis by Market Taxonomy
16.11.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
16.11.2.1. By Type
16.11.2.2. By Usage
16.12. China Breast Lesion Localization Market Analysis
16.12.1. Value Proportion Analysis by Market Taxonomy
16.12.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
16.12.2.1. By Type
16.12.2.2. By Usage
16.13. Japan Breast Lesion Localization Market Analysis
16.13.1. Value Proportion Analysis by Market Taxonomy
16.13.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
16.13.2.1. By Type
16.13.2.2. By Usage
16.14. South Korea Breast Lesion Localization Market Analysis
16.14.1. Value Proportion Analysis by Market Taxonomy
16.14.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
16.14.2.1. By Type
16.14.2.2. By Usage
16.15. GCC Countries Breast Lesion Localization Market Analysis
16.15.1. Value Proportion Analysis by Market Taxonomy
16.15.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
16.15.2.1. By Type
16.15.2.2. By Usage
16.16. South Africa Breast Lesion Localization Market Analysis
16.16.1. Value Proportion Analysis by Market Taxonomy
16.16.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
16.16.2.1. By Type
16.16.2.2. By Usage
16.17. Turkey Breast Lesion Localization Market Analysis
16.17.1. Value Proportion Analysis by Market Taxonomy
16.17.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
16.17.2.1. By Type
16.17.2.2. By Usage
16.17.3. Competition Landscape and Player Concentration in the Country
17. Market Structure Analysis
17.1. Market Analysis by Tier of Companies
17.2. Market Concentration
17.3. Market Share Analysis of Top Players
17.4. Market Presence Analysis
17.4.1. By Regional footprint of Players
17.4.2. Product footprint by Players
18. Competition Analysis
18.1. Competition Dashboard
18.2. Competition Benchmarking
18.3. Competition Deep Dive
18.3.1. Hologic, Inc.
18.3.1.1. Overview
18.3.1.2. Product Portfolio
18.3.1.3. Sales Footprint
18.3.1.4. Strategy Overview
18.3.2. Becton, Dickinson and Company
18.3.2.1. Overview
18.3.2.2. Product Portfolio
18.3.2.3. Sales Footprint
18.3.2.4. Strategy Overview
18.3.3. Merit Medical Systems
18.3.3.1. Overview
18.3.3.2. Product Portfolio
18.3.3.3. Sales Footprint
18.3.3.4. Strategy Overview
18.3.4. Leica Biosystems Nussloch GmbH
18.3.4.1. Overview
18.3.4.2. Product Portfolio
18.3.4.3. Sales Footprint
18.3.4.4. Strategy Overview
18.3.5. Argon Medical Devices
18.3.5.1. Overview
18.3.5.2. Product Portfolio
18.3.5.3. Sales Footprint
18.3.5.4. Strategy Overview
18.3.6. Laurane Medical LLC
18.3.6.1. Overview
18.3.6.2. Product Portfolio
18.3.6.3. Sales Footprint
18.3.6.4. Strategy Overview
18.3.7. Endomagnetics Ltd.
18.3.7.1. Overview
18.3.7.2. Product Portfolio
18.3.7.3. Sales Footprint
18.3.7.4. Strategy Overview
18.3.8. Intramedical Imaging, LLC
18.3.8.1. Overview
18.3.8.2. Product Portfolio
18.3.8.3. Sales Footprint
18.3.8.4. Strategy Overview
18.3.9. Isoaid
18.3.9.1. Overview
18.3.9.2. Product Portfolio
18.3.9.3. Sales Footprint
18.3.9.4. Strategy Overview
19. Assumptions and Acronyms Used
20. Research Methodology
Explore Healthcare Insights
View Reports
Breast Lesion Localization Market
